Prof. Anthony Serracino Inglott

Prof. Anthony Serracino Inglott

Prof. Anthony Serracino Inglott

 B.Pharm.,Pharm.D.(Cinc.),M.A.C.C.P.,M.R.Pharm.S.

Professor

Room 236
Biomedical Sciences Building
University of Malta
Msida
  +356 2340 2901
Anthony Serracino-Inglott BPharm,PharmD is a Professor of Pharmacy at the University of Malta. He studied pharmacy in Malta and the United States. He received a Doctor of Pharmacy degree in 1972 from the University of Cincinnati. He completed a Residency under the supervision of Don E. Francke in the US. He is a registered pharmacist in Malta and the United Kingdom. His research interests are in the fields of biopharmaceutics and pharmacokinetics, pharmaceutical regulatory sciences, patient safety, personalised medicines and pharmacy education.
Serracino-Inglott contributed to the evolvement of pharmacy health-systems across the globe through his high profile interventions as consultant to ministers of health and education and during his participation in international meetings such as at the World Health Organisation where he championed collaborative involvement of pharmacists. He was instrumental in developing clinical pharmacy services and establishing hospital interprofessional practices and collaborative healthcare higher education models. He is active in pharmaceutical regulatory sciences leading to international collaboration in propagating safety, efficacy and quality of medicines. He is currently chairperson of the Malta Medicines Authority and a member of the Management Board of the European Medicines Agency.
Professor Serracino-Inglott has spearheaded innovations in pharmacy education including teaching models which support critical thinking competences. He is a key academic in the innovative post-graduate international doctorate in pharmacy offered by the University of Malta in collaboration with the University of Illinois at Chicago. Anthony Serracino-Inglott participates actively in the activities of the European Association of Faculties of Pharmacy, the European Society of Clinical Pharmacy and the International Pharmaceutical Federation.
  • Clinical Pharmacy
  • Pharmaceutical technology
  • Pharmaceutical regulatory affairs
  • Pharmaceutical analysis
  • Pharmacy Practice

AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2020. An inter-professional approach towards understanding the science, myths and realities of COVID-19 pandemic: Innovation in teaching delivery or learning technology. Pharmacy Education, , pp. 33-34.

AZZOPARDI, L.M. and SERRACINO‐INGLOTT, A., 2020. Clinical pharmacy education and practice evolvement in Malta. Journal of the American College of Clinical Pharmacy, 3(5), pp. 973-979.

BARTOLO, N.S., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2020. Pharmaceuticals and the environment. Early human development, , pp. 105218.

BARTOLO, N.S., ZOIDIS, G., GIKAS, E., BENAKI, D., FERRITO, V. and SERRACINO-INGLOTT, A., 2020. A multi-technique analytical approach for impurity profiling during synthesis: The case of difluprednate. Journal of pharmaceutical and biomedical analysis, 190, pp. 113483.

SAMMUT BARTOLO, N., IGNAS, L., WIRTH, F., ATTARD PIZZUTO, M., VELLA SZIJJ, J., CAMILLERI, L., SERRACINO‐INGLOTT, A. and AZZOPARDI, L.M., 2020. Public perception of generic medicines in Malta. Journal of Pharmaceutical Health Services Research, 11(3), pp. 295-298.

SAMMUT BARTOLO, N., ZOIDIS, G., GIKAS, E., BENAKI, D., FERRITO, V. and SERRACINO-INGLOTT, A., 2020. A multi-technique analytical approach for impurity profiling during synthesis: the case of difluprednate.

ZUCCARELLI, M., VELLA-SZIJJ, J., SERRACINO-INGLOTT, A. and BORG, J., 2020. Treatment of Leber’s hereditary optic neuropathy: An overview of recent developments. European journal of ophthalmology, , pp. 1120672120936592.

ABBAS, A., VELLA SZIJJ, J., AZZOPARDI, L.M. and SERRACINO INGLOTT, A., 2019. Orphan drug policies in different countries. Journal of Pharmaceutical Health Services Research, 10(3), pp. 295-302.

ATTARD PIZZUTO, M., CAMILLERI, L., AZZOPARDI, L.M. and SERRACINO‐INGLOTT, A., 2019. Exploring views of pharmacists on antibacterial prescribing: a Maltese perspective. International Journal of Pharmacy Practice, 27(3), pp. 256-263.

BORG, J., MELCHIORRI, D., SEPODES, B., CARAMELLA, C.M., TOMINO, C., MICALLEF, B., SERRACINO-INGLOTT, A. and NISTICO, R., 2019. Optimising bench science to withstand regulatory scrutiny. Pharmacological research, 139, pp. 491.

BUHAGIAR, L.M., MICALLEF, B., BORG, J.J., VELLA, H., INGLOTT, A.S. and LAFERLA, G., 2019. Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in point. Drug metabolism and personalized therapy, 34(2),.

GAUCI, M., WIRTH, F., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2019. Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons. Pharmacy Practice (Granada), 17(1),.

MIFSUD BUHAGIAR, L., SAMMUT, C., CHIRCOP, Y., AXISA, K., SAMMUT BARTOLO, N., VELLA SZIJJ, J., SERRACINO INGLOTT, A. and LAFERLA, G., 2019. Practical liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of amitriptyline, nortriptyline and their hydroxy metabolites in human serum. Biomedical Chromatography, 33(12), pp. e4679.

MIFSUD, E.M., WIRTH, F., CAMILLERI, L., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2019. Pharmacist-led medicine use review in community pharmacy for patients on warfarin. International journal of clinical pharmacy, 41(3), pp. 741-750.

AQUILINA, A., WIRTH, F., ATTARD PIZZUTO, M., GRECH, L., CAMILLERI, L., AZZOPARDI, L.M. and SERRACINO‐INGLOTT, A., 2018. Preparing for pharmacist prescribing in Maltese hospitals. Journal of Pharmaceutical Health Services Research, 9(3), pp. 237-243.

CILIA, M., RUIZ, S., RICHARDSON, P., SALMONSON, T., SERRACINO-INGLOTT, A., WIRTH, F. and BORG, J.J., 2018. Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency’s Committee for Medicinal Products for Human Use. AAPS PharmSciTech, 19(2), pp. 489-511.

GAUCI, M., WIRTH, F., AZZOPARDI, L.M. and SERRACINO‐INGLOTT, A., 2018. Clinical pharmacist implementation of a medication assessment tool for secondary prevention of stroke in older persons. Journal of Pharmaceutical Health Services Research, 9(3), pp. 207-214.

VELLA, J., WIRTH, F., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2018. Serum digoxin concentrations: a retrospective analysis.

ANASTASI, A., GRECH, L., INGLOTT, A.S. and AZZOPARDI, L.M., 2017. CP-185 An innovative treatment adherence tool. British Medical Journal Publishing Group.

GAUCI, M., WIRTH, F., CAMILLERI, L., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2017. Design and application of a medication assessment tool for secondary prevention of stroke. International Journal of Clinical Pharmacy, 39(5), pp. 1008-1012.

TANTI, A., CAMILLERI, M., BORG, A.A., MICALLEF, B., FLORES, G., SERRACINO-INGLOTT, A. and BORG, J.J., 2017. Opinions of Maltese doctors and pharmacists on medication errors. International Journal of Risk & Safety in Medicine, 29(1-2), pp. 81-99.

TANTI, A., MICALLEF, B., SERRACINO-INGLOTT, A. and BORG, J., 2017. A review of the National pharmacovigilance system in Malta–implementing and operating a pharmacovigilance management system. Expert opinion on drug safety, 16(1), pp. 65-76.

ATTARD PIZZUTO, M., CAMILLERI, L., SERRACINO‐INGLOTT, A. and AZZOPARDI, L.M., 2016. Practices and perceptions of medical practitioners on potential antibiotic prescribing by pharmacists. Journal of Pharmaceutical Health Services Research, 7(3), pp. 157-164.

GRECH, L., FERRITO, V., SERRACINO INGLOTT, A. and AZZOPARDI, L.M., 2016. Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management. Journal of Pharmaceutical Health Services Research, 7(1), pp. 89-92.

VELLA, J., VELLA, M., CASSAR, K., CAMILLERI, L., SERRACINO-INGLOTT, A., AZZOPARDI, L.M. and LAFERLA, G., 2016. Factors affecting penetration of ciprofloxacin in lower extremity ischemic tissues. The international journal of lower extremity wounds, 15(2), pp. 126-131.

BORG, J.J., ANKER, S.D., ROSANO, G., SERRACINO-INGLOTT, A. and STRASSER, F., 2015. Multimodal management as requirement for the clinical use of anticachexia drugs-a regulatory and a clinical perspective. Current Opinion in Supportive and Palliative Care, 9(4), pp. 333-345.

BORG, J.J., TANTI, A., KOUVELAS, D., LUNGU, C., PIROZYNSKI, M., SERRACINO-INGLOTT, A. and AISLAITNER, G., 2015. European Union pharmacovigilance capabilities: potential for the new legislation. Therapeutic advances in drug safety, 6(4), pp. 120-140.

BUGEJA, A., PIZZUTO, M.A., SERRACINO-INGLOTT, A. and AZZOPARDI, L.M., 2015. Pharmacist intervention in a psychiatric setting. European Journal of Hospital Pharmacy, 22(5), pp. 280-284.

MICALLEF, B., ATTARD, E., SERRACINO-INGLOTT, A. and BORG, J.J., 2015. Could EU herbal monographs contribute to Malta’s treatment armamentarium? Phytomedicine, 22(3), pp. 400-405.

TANTI, A., SERRACINO INGLOTT, A. and BORG, J., 2015. Designing a national combined reporting form for adverse drug reactions and medication errors. EMHJ-Eastern Mediterranean Health Journal, 21(4), pp. 246-255.

UNGARO, S., WIRTH, F., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2015. Point-of-care testing for urine analysis and microalbuminuria for diabetic patient management. Point of Care, 14(3), pp. 71-72.

VELLA, J., BUSUTTIL, F., BARTOLO, N.S., SAMMUT, C., FERRITO, V., SERRACINO-INGLOTT, A., AZZOPARDI, L.M. and LAFERLA, G., 2015. A simple HPLC–UV method for the determination of ciprofloxacin in human plasma. Journal of Chromatography B, 989, pp. 80-85.

BORG, J.J., SERRACINO-INGLOTT, A., AZZOPARDI, L.M. and SCHNEIDER, C.K., 2014. Comment On:“EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”. Drug safety, 37(2), pp. 123-124.

GALEA, S., ZARB ADAMI, M., SERRACINO‐INGLOTT, A. and AZZOPARDI, L.M., 2014. Pharmacist interventions in non‐prescription medicine use. Journal of Pharmaceutical Health Services Research, 5(1), pp. 55-59.

MAMO, M., WIRTH, F., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2014. Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta. European Journal of Hospital Pharmacy: Science and Practice, 21(1), pp. 49-53.

MIFSUD, E.M., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2014. Proposing a framework for international normalized ratio testing and anticoagulation management in community pharmacies. Point of Care, 13(4), pp. 125-127.

MIFSUD, M., VELLA, J., FERRITO, V., SERRACINO-INGLOTT, A., AZZOPARDI, L.M., SAMMUT BARTOLO, N., LAFERLA, G. and SAMMUT, C., 2014. A simple HPLC-UV method for the determination of clindamycin in human plasma.

AQUILINA, S., AZZOPARDI, L.M. and SERRACINO-INGLOTT, A., 2013. Impacting cardiovascular disease risk management.

BALDACCHINO, S., CAMILLERI, L., FAVA, S., SERRACINO-INGLOTT, A. and AZZOPARDI, L.M., 2013. Risk Assessment Models for the Development of Complications in Maltese Type 2 Diabetic Patients. J Diabetes Metab, 4(2), pp. 1-6.

BUHAGIAR, L.M., CASSAR, O.A., BRINCAT, M.P., BUTTIGIEG, G.G., INGLOTT, A.S., ADAMI, M.Z. and AZZOPARDI, L.M., 2013. Pre-operative pain sensitivity: a prediction of post-operative outcome in the obstetric population. Journal of anaesthesiology, clinical pharmacology, 29(4), pp. 465.

GRECH, L., COLEIRO, B., BORG, A., SERRACINO INGLOTT, A. and AZZOPARDI, L.M., 2013. Evaluation of the impact of a pharmaceutical care service offered to rheumatoid arthritis patients within an ambulatory setting.

MERCIECA, C., SERRACINO‐INGLOTT, A. and AZZOPARDI, L.M., 2013. Perceptions of a newsletter for community pharmacists. Journal of Pharmaceutical Health Services Research, 4(2), pp. 101-103.

PACE, A., AZZOPARDI, L.M., SERRACINO-INGLOTT, A., WISMAYER, L. and ADAMI, M.Z., 2013. Development in the European Union and access to medicines. Pharmacie Globale, 4(6), pp. 1.

SAID, C., COLEIRO, B., ZARB ADAMI, M., AZZOPARDI, L.M. and SERRACINO INGLOTT, A., 2013. Cost Effectiveness of TNF-Inhibitors in Rheumatoid Arthritis. International journal of inflammation, 2013.

SPITERI, M., ATTARD, E., SERRACINO-INGLOTT, A. and AZZOPARDI, L.M., 2013. Compilation of a herbal medicine formulary for herbal substances in Malta and its usefulness amongst healthcare professionals. Journal of Young Pharmacists, 5(1), pp. 22-25.

SAPIANO, K., SAVONA-VENTURA, C., CALLEJA-AGIUS, J., SERRACINO-INGLOTT, A. and AZZOPARDI, L., 2012. Attitudes towards pre-conception care in Maltese women with Type 1 Diabetes Mellitus. Gynaecological Endocrinology, 12(Dec 28), pp. 1006-1009.

BUHAGIAR, L., CASSAR, O., BRINCAT, M., BUTTIGIEG, G., SERRACINO-INGLOTT, A., ZARB-ADAMI, M. and AZZOPARDI, L., 2011. Predictors of post-caeserean section pain and analgesic consumption. Journal of Anaesthesiology Clinical Pharmacology, 27(2), pp. 185-191.

CAMILLERI, L., SCHEMBRI, A. and SERRACINO-INGLOTT, A., 2011. Prevalence, characteristics and management of endometriosis in an infertile Maltese population. International Journal of Gynaecology and Obstetrics, 115(5), pp. 293-294.

FENECH, J., GALEA, R., SERRACINO-INGLOTT, A. and AZZOPARDI, L., 2011. Management and patient knowledge of osteoporosis. Journal of Applied Therapeutic Research, 8, pp. 101-106.

PIROTTA, I., AZZOPARDI, L. and SERRACINO-INGLOTT, A., 2011. Patient management in colorectal cancer. Hospital Pharmacy Europe, 58, pp. 24-26.

SACCO, R., AZZOPARDI, L. and SERRACINO-INGLOTT, A., 2011. Palliative care in cancer patients:  evaluating pharmacist intervention in a hospice setting. European Journal of Hospital Pharmacy, 17(3), pp. 75-80.

GRISCTI, S., SERRACINO-INGLOTT, A., ZARB-ADAMI, M., AZZOPARDI, L., ANASTASI, A., MALLIA, C., AZZOPARDI, L., CAMILLERI VASSALLO, F., CASSAR, PJ., COLEIRO, B., CASSAR, K. and AQUILINA, D., 2010. Management of rheumatoid arthritis. Hospital Pharmacy Europe, March/April.

WIRTH, F., TABONE, F., AZZOPARDI, L.M., GAUCI, M., ZARB‐ADAMI, M. and SERRACINO‐INGLOTT, A., 2010. Consumer perception of the community pharmacist and community pharmacy services in Malta. Journal of Pharmaceutical Health Services Research, 1(4), pp. 189-194.

CONTI, L., WIRTH, F., AZZOPARDI, L., MALLIA, C., CAMILLERI VASSALLO, F., COLEIRO, B., CASSAR, P.J., CASSAR, K., AZZOPARDI, L.M. and ZARB ADAMI, M., 2009. Pharmaceutical care aspects in systemic lupus erythematosus.

MANDUCA, E., AZZOPARDI, L., MANCHE, A., ZARB-ADAMI, M. and SERRACINO-INGLOTT, A., 2009. Tolerance to an 8mg dose of perindopril for secondary prevention of coronary artery disease. Hospital Pharmacy Europe, 43, pp. 54-57.

PIZZUTO, M., WIRTH, F., AZZOPARDI, L., ZARB-ADAMI, M. and SERRACINO-INGLOTT, A., 2009. Palliative care in cancer patients. Hospital Pharmacy Europe, 42, pp. 66-69.

VELLA, E., AZZOPARDI, L.M., ZARB‐ADAMI, M. and SERRACINO‐INGLOTT, A., 2009. Development of protocols for the provision of headache and back‐pain treatments in Maltese community pharmacies. International Journal of Pharmacy Practice, 17(5), pp. 269-274.

WIRTH, F., AZZOPARDI, L.M., GAUCI, M., ADAMI, M.Z. and SERRACINO‐INGLOTT, A., 2009. Time and motion study for pharmacists' activities in a geriatric hospital. International Journal of Pharmacy Practice, 17(6), pp. 373-376.

AQUILINA, S., AZZOPARDI, L., ZARB-ADAMI, M. and SERRACINO-INGLOTT, A., 2008. Disease management in community pharmacy. Hospital Pharmacy Europe, 38, pp. 22-24.

AZZOPARDI, L., SERRACINO-INGLOTT, A. and ZARB-ADAMI, M., 2007. Writing examination and assessment papers. In: M. STUART, ed, The complete guide to medical writing. London: Pharmaceutical Press, .

FENECH, N., AZZOPARDI, L., MUSCAT, V., ZARB-ADAMI, M. and SERRACINO-INGLOTT, A., 2007. Control of nausea and vomiting in cancer chemotherapy. Clinical Pharmacy Europe, 7, pp. 14-16.

ZAMMIT, L., AZZOPARDI, L., SERRACINO-INGLOTT, A., ZARB-ADAMI, M. and CACCIOTTOLO, J., 2006. Compliance and antihypertensive therapy. Clinical Pharmacy Europe, 3, pp. 41-42.

AQUILINA, S., GALEA, L., SCERRI, L., AZZOPARDI, L. and INGLOTT, A., 2003. Assessment of the quality of life in patients with acne. Journal of the European Academy of Dermatology & Venereology, 17.

AZZOPARDI, L.M., SERRACINO‐INGLOTT, A., SALEK, S. and ZARB‐ADAMI, M., 2003. Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists. The Quality Assurance Journal: The Quality Assurance Journal for Pharmaceutical, Health and Environmental Professionals, 7(4), pp. 248-257.

AZZOPARDI, L.M., SALEK, S., SERRACINO-INGLOTT, A., ZARB-ADAMI, M. and BUHAGIAR, A., 2001. Validating tools for the monitoring of community pharmacy services.

MICALLEF, M.J., DARMANIN, S., BUHAGIAR, J.A., CAMILLERI-PODESTA, M., YAMAUCHI, H., KURIMOTO, M., INGLOTT, A.S. and ELLUL-MICALLEF, R., 2001. Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-γ. International immunopharmacology, 1(2), pp. 295-305.

SERRACINO-INGLOTT, A. and RIZZO NAUDI, J., 1992. Drugs in the elderly. Malta: University Press.

INGLOTT, A.S., 1972. Electrolyte Solutions and Body Fluids I. Use of Milliequivalent and Milliosmol. Drug intelligence & clinical pharmacy, 6(1), pp. 28-31.

  • PHR1101 - Pharmacy Practice 1
  • PHR1605 - Communication in Pharmacy
  • PHR2103 - Pharmacy Practice 2
  • PHR2442 - Applied Pharmaceutical Biochemistry
  • PHR2602 - Applied Pharmaceutical Sciences
  • PHR3106 - Pharmacy Practice 3
  • PHR3605 - Pharmaceutical Validation
  • PHR4112 - Pharmacy Practice 4
  • PHR5005 - Industrial Pharmacy
  • PHR5008 - Specialisation in Industrial Pharmacy
  • PHR5010 - Pharmaceutical Regulatory Sciences
  • PHR5011 - Pharmacovigilance
  • PHR5013 - Specialisation in Pharmaceutical Regulatory Sciences
  • PHR5515 - Clinical Pharmacy
  • PHR5617 - Pharmacotherapeutics 2
Collaboration with local pharmaceutical industry

Awards
1970 Drug Intelligence and Clinical Pharmacy Award for Research in Parenteral Products
1972 Bristol Award for Outstanding Research in Clinical Pharmacy
2011 Award by the International Association of Pharmaceutical Technology

Affiliations and Memberships
Registered as a Pharmacist, Malta
Registered as a Qualified Person, Malta
General Pharmaceutical Council, UK
European Society of Clinical Pharmacy
International Association of Pharmaceutical Technology
International Pharmaceutical Federation
Royal Pharmaceutical Society, UK

https://www.um.edu.mt/_templates/staffprofiles